Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results
Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for fiscal 2023.
The Indianapolis-based pharmaceutical company said its revenues declined 11% year-over-year to $6.96 billion in the first quarter, hurt by lower realized prices and a decline in volumes.
The weak top-line performance translated into a 38% fall in net earnings, on an adjusted basis, to $1.62 per share. Unadjusted profit decreased to $1.34 billion or $1.49 per share from $1.90 billion or $2.10 per share in the first quarter of 2022.
“Core business growth drove solid first-quarter financial results and a strong start for Lilly in 2023, which includes pipeline progress led by positive SURMOUNT-2 data for tirzepatide in obesity,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
United Airlines (UAL) Earnings: 4Q24 Key Numbers
United Airlines (NASDAQ: UAL) reported total operating revenue of $14.7 billion for the fourth quarter of 2024, up 7.8% compared to the same period last year. Net income increased 64%
Highlights of Abbott Laboratories (ABT) Q4 2024 results
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted profit. Total reported sales increased 7.2% year-over-year to
PG Earnings: Key quarterly highlights from Procter & Gamble’s Q2 2025 financial results
The Procter & Gamble Company (NYSE: PG) reported its second quarter 2025 earnings results today. Net sales were $21.9 billion, up 2% from the prior-year quarter. Organic sales increased 3%.